May 10th 2024
While Moderna expects mRNA-1345 to be approved later this month, the company cites FDA administrative constraints as reason for delay.
April 30th 2024
Your daily dose of the clinical news you may have missed.
April 22nd 2024
Researchers found that the COVID-19 booster dose elicited a 71%-84% increase in the median anti-spike half-life over that of the primary series.
March 29th 2024
Investigators found vaccine uptake of 41% among unvaccinated individuals who were part of a messaging intervention in the emergency department.
March 19th 2024
The novel 21-valent pneumococcal vaccine remains on track for the FDA PDUFA date of June 17, 2024; Merck adds this new data to the body of positive evidence.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 1, 2021
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
FDA Advisory Committee Narrowly Backs Merck’s Oral COVID-19 Antiviral
The 13-10 vote was not without controversy as panel members discussed concerns over the novel antiviral's safety risks and modest efficacy.
Omicron Variant Update: Notes on Headline News 12-1-2021
The Omicron variant of COVID-19 was today identified for the first time in the US, according to the CDC. Get a topline look at other recent breaking news in this slide show.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 30, 2021
Omicron Variant is Moving Quickly but Much Remains Unknown, says WHO
The Omicron variant of the SARS-CoV-2 virus is spreading quickly, jumping continents with infected travelers. The best protection remains vaccination and indoor precautions.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 23, 2021
COVID-19 Cases, Hospitalizations Up: Top 5 States Reporting Increases
COVID-19 cases are up by double digits in many states and hospitalizations have made big leaps in others. We report the top 5 in each category for the 7 days from 11/14-21.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 22, 2021
FDA, CDC Authorize Use of Pfizer, Moderna Booster Shots for Every US Adult
Booster doses for US adults at least 18 years of age are expected to be available as soon as this weekend.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 19, 2021
COVID-19 Misinformation Still Rampant in US: Kaiser Family Foundation Findings
New survey finds 78% of US adults either believe or are unsure about at least 4 of 8 COVID-19 myths tested, with unvaccinated adults among the most likely to hold misconceptions.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 16, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 15, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 12, 2021
Study Finds COVID-19 Antibodies in Breast Milk of Vaccinated Mothers
Mothers vaccinated against COVID-19 produced robust IgG antibodies in breast milk that actively neutralized the SARS-CoV-2 virus, according to investigators.
Pfizer Submits Request to Expand COVID-19 Booster EUA to All US Adults
Pfizer-BioNTech included data in its FDA submission showing the 3rd mRNA shot restores protection against symptomatic COVDI-19 to about 95%.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 10, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 9, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 8, 2021
Effectiveness Declines for All 3 COVID-19 Vaccines Over Time in Large Veterans Study
Efficacy of COVID-19 vaccines from Pfizer, Moderna, and J&J fell between 35% and 85% among nearly 800 000 US veterans, found a consortium of investigators.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 4, 2021
CDC Signs Off on Pfizer’s COVID-19 Vaccine for Children Aged 5-11 Years
CDC Director Rochelle Walensky officially endorsed Pfizer's COVID-19 vaccine in children aged 5 to 11 years, following recommendation from ACIP.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of November 2, 2021
Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of November 1, 2021
Global confirmed deaths due to COVID-19 have surpassed 5 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map and the CDC.
Influenza Vaccination During COVID-19: 5 Questions for Primary Care
COVID-19 has changed many of what we know as standard operating procedures during flu season. How would you handle these 5 situations, for example?
Flu Season 2021-2022: Primary Care Fears & Patients on the Fence
This flu season will bring different challenges to primary care clinicians. Here, experts discuss specific barriers and best strategies to overcome them.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 29, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 28, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 27, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 26, 2021